Compare NNNN & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | PRA |
|---|---|---|
| Founded | 2021 | 1976 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2025 | N/A |
| Metric | NNNN | PRA |
|---|---|---|
| Price | $33.50 | $24.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.50 |
| AVG Volume (30 Days) | 37.4K | ★ 427.9K |
| Earning Date | 04-28-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.06 | ★ 0.66 |
| Revenue | $6,920,153.00 | ★ $1,120,385,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.24 |
| P/E Ratio | $554.67 | ★ $36.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.18 | $13.90 |
| 52 Week High | $55.65 | $24.41 |
| Indicator | NNNN | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.21 | 56.87 |
| Support Level | $32.93 | $24.03 |
| Resistance Level | $43.00 | $24.24 |
| Average True Range (ATR) | 4.09 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 33.23 | 73.91 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.